aTyr Pharma, Inc. (ATYR) Tops Q2 EPS by 1c

aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.

You May Also Be Interested In

• Chinese Long March 7A Rocket Appears To Break Apart After Liftoff - Reuters Witnesses
• On Holding AG (ONON) call put ratio 3.1 calls to 1 put with a focus on August 14 weekly calls into quarter results
• Corpay (CPAY) PT Raised to $480 at Cantor Fitzgerald